Great Point Partners LLC Unicycive Therapeutics, Inc. Transaction History

Great Point Partners LLC

  • $121 Million
  • Q2 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.35 - $0.81 $847,350 - $1.96 Million
2,421,000 Added 28.29%
10,980,000 $8.67 Million
Q3 2024

Nov 13, 2024
BUY
$0.24 - $0.54 $2.05 Million - $4.62 Million
8,559,000 New
8,559,000 $3.51 Million

Others Institutions Holding UNCY

# of Institutions
3
Shares Held
70.8K
Call Options Held
0
Put Options Held
0
View Full List

About Unicycive Therapeutics, Inc.

UNCY Quotes by TradingView
  • Ticker UNCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,052,500
  • Market Cap $64.9M
  • Description
  • Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Al...
More about UNCY
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email